Ceftazidime–avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections

Overview of attention for article published in Core Evidence, January 2014

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 4,356 followers.

Avibactam: the first new b-lactamase inhibitor in decades combined w Ceftaz found comparable to carbapenems for c-UTI http://t.co/qNYFX9v4Yy

Avibactam: the first new b-lactamase inhibitor in decades will be a big deal in the fight against resistant infxns http://t.co/qNYFX9v4Yy

Avibactam: the first new b-lactamase inhibitor in decades will be a big deal in the fight against resistant infxns http://t.co/qNYFX9v4Yy

Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of... http://t.co/Op1sTFnPRV

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.